• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Acquisition

A map of the state of New Jersey
Manufacturing

Korea's Celltrion throws down $330M for Lilly plant in N.J.

After teasing its position in a bidding contest for a large U.S. drug substance plant this summer, South Korea’s Celltrion has sealed the deal.
Fraiser Kansteiner Sep 23, 2025 9:24am
Graphic of two hands shaking under a red and purple light

PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT

Sep 11, 2025 10:25am
puzzle pieces merger and acquisition business concept

CorMedix buys Melinta for $300M, adding 7 marketed products

Aug 7, 2025 11:36am
Photo of a solo traveler or walker on a hanging bridge in the forest

Merck had no other competition in its $10B buyout of Verona

Aug 7, 2025 7:00am
acquisition merger arrows

Publicis Health picks up p-value medical comms group

Jul 29, 2025 11:30am
Real Chemistry Greater Than One acquisition

Real Chemistry grows Greater Than One in new acquisition

Jul 22, 2025 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings